Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    D,L-O-Desmethyl Venlafaxine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Aspen Pharmacare Holdings

    02 4Alfred E Tiefenbacher GmbH

    03 2ANGITA PHARMA INC.

    04 3Actavis Inc

    05 2Adcock Ingram

    06 2Adelco-Chromatourgia Anthinon E. Colocotronis Bros S.A.

    07 5Alembic Pharmaceuticals Limited

    08 8Alphapharm PTY Ltd

    09 2Anchen Pharmaceutical, Inc

    10 6Apotex Inc

    11 4Arrow Pharmaceuticals

    12 2Ascent Innovative Medicines

    13 2Aspire Lifesciences Pvt Ltd

    14 2Cipla Medpro South Africa

    15 2Eurofarma Laboratorios S.A

    16 4Generic Health

    17 3Hikma Pharmaceuticals

    18 2INNOVATA PHARMACEUTICALS

    19 2JAMP PHARMA

    20 1Jivita Health Care

    21 2LABORATORIOS NORMON SA

    22 3Lupin Ltd

    23 2MEDICAP LABS

    24 2Macleods Pharmaceuticals Limited

    25 2Neuraxpharm

    26 2Osmotica Pharmaceuticals

    27 2PHARMOBEDIENT

    28 2PRO DOC LIMITEE

    29 4Pfizer Consumer Healthcare

    30 11Pfizer Inc

    31 2Pharma Dynamics

    32 2Precise Group

    33 3Rubicon Research

    34 2SANIS HEALTH INC

    35 2SIVEM PHARMACEUTICALS ULC

    36 14Sandoz B2B

    37 2Taro Pharmaceutical Industries

    38 2Teva Pharmaceutical Industries

    39 4WAGNER PHARMACEUTICALS PTY LTD

    40 2Waymade

    41 8Yichang Humanwell Pharmaceutical

    42 3Zydus Pharmaceuticals

    43 2Blank

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Aspen Pharmacare Holdings

    South Africa
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag South Africa
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : South Africa

    Desvenlafaxine

    Brand Name : Voloxin 50mg

    Dosage Form : TAB

    Dosage Strength : 50mg

    Packaging : 28X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    Aspen API Comapny Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Alfred E Tiefenbacher GmbH

    Germany
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    desvenlafaxine

    Brand Name :

    Dosage Form : Prolonged Release tablet

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    Tiefenbacher Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Aspen Pharmacare Holdings

    South Africa
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Contact Supplier Contact Supplier
    Flag South Africa
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Generic

    Registration Country : South Africa

    Desvenlafaxine

    Brand Name : Voloxin 100mg

    Dosage Form : TAB

    Dosage Strength : 100mg

    Packaging : 28X1mg

    Approval Date :

    Application Number :

    Regulatory Info : Generic

    Registration Country : South Africa

    Aspen API Comapny Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Alfred E Tiefenbacher GmbH

    Germany
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    desvenlafaxine

    Brand Name :

    Dosage Form : Prolonged Release tablet

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    Tiefenbacher Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Alfred E Tiefenbacher GmbH

    Germany
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    desvenlafaxine

    Brand Name :

    Dosage Form : Prolonged Release tablet

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    Tiefenbacher Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Alfred E Tiefenbacher GmbH

    Germany
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    desvenlafaxine

    Brand Name :

    Dosage Form : Prolonged Release tablet

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : EU Dossier Readiness-Q1 2020

    Registration Country : Germany

    Tiefenbacher Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Alembic Pharmaceuticals Limited

    India
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Alembic Pharmaceuticals Limited

    India
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 2015-06-29

    Application Number : 204003

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Alembic Pharmaceuticals Limited

    India
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Alembic Pharmaceuticals Limited

    India
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2015-06-29

    Application Number : 204003

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Alembic Pharmaceuticals Limited

    India
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Alembic Pharmaceuticals Limited

    India
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2018-09-14

    Application Number : 204003

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Anchen Pharmaceutical, Inc

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Anchen Pharmaceutical, Inc

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    DESVENLAFAXINE

    Brand Name : DESVENLAFAXINE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number : 204009

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Anchen Pharmaceutical, Inc

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Anchen Pharmaceutical, Inc

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    DESVENLAFAXINE

    Brand Name : DESVENLAFAXINE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number : 204009

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Pfizer Inc

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Pfizer Inc

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : PRISTIQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 2008-02-29

    Application Number : 21992

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Pfizer Inc

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Pfizer Inc

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : PRISTIQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2008-02-29

    Application Number : 21992

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Pfizer Inc

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Pfizer Inc

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : PRISTIQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2014-08-20

    Application Number : 21992

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Rubicon Research

    India
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Rubicon Research

    India
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 2015-06-29

    Application Number : 204028

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Rubicon Research

    India
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Rubicon Research

    India
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2015-06-29

    Application Number : 204028

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Rubicon Research

    India
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Rubicon Research

    India
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2023-12-07

    Application Number : 204028

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Zydus Pharmaceuticals

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Zydus Pharmaceuticals

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 2017-10-11

    Application Number : 204020

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Zydus Pharmaceuticals

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Zydus Pharmaceuticals

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2017-10-11

    Application Number : 204020

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Zydus Pharmaceuticals

    U.S.A
    Stanford Drug Discovery Symposium
    Not Confirmed
    arrow

    Zydus Pharmaceuticals

    U.S.A
    arrow
    Stanford Drug Discovery Symposium
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DESVENLAFAXINE SUCCINATE

    Brand Name : DESVENLAFAXINE SUCCINATE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2022-11-30

    Application Number : 204020

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.